Decoding 13 Analyst Evaluations For Elevance Health
Decoding 13 Analyst Evaluations For Elevance Health
解碼 13 項分析師對 Elevance Health 的評估
Analysts' ratings for Elevance Health (NYSE:ELV) over the last quarter vary from bullish to bearish, as provided by 13 analysts.
13位分析師提供的分析師對Elevance Health（紐約證券交易所代碼：ELV）在上個季度的評級從看漲到看跌不等。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天中情緒的變化，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $586.0, a high estimate of $621.00, and a low estimate of $547.00. Witnessing a positive shift, the current average has risen by 2.11% from the previous average price target of $573.89.
分析師分析的12個月目標股價提供了見解，平均目標價爲586.0美元，最高估計爲621.00美元，低估值爲547.00美元。當前的平均價格從之前的平均目標價573.89美元上漲了2.11％，這是一個積極的轉變。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級：深度分析
A clear picture of Elevance...
通過對分析...
登入免費觀看全文
登入/註冊